Clinical Trial Detail

NCT ID NCT02839694
Title Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

germ cell cancer

sarcoma

melanoma

Therapies

Decitabine + Tetrahydrouridine

Celecoxib + Decitabine + Tetrahydrouridine

Age Groups: adult senior

No variant requirements are available.